{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:32:42Z","timestamp":1787031162255,"version":"build-2736575974"},"reference-count":34,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Hepatol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Sarcopaenia is associated with a two-fold higher mortality rate in patients with cirrhosis independent of liver disease severity. Few treatments for cirrhosis related sarcopaenia exist beyond optimal nutritional management.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To assess if rifaximin-\u03b1, a minimally absorbed antimicrobial used to manage hepatic encephalopathy (HE), may improve sarcopaenia in cirrhosis through its ammonia lowering and anti-inflammatory properties.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>This single-centre retrospective cohort study of patients with prior HE compared patients treated with lactulose alone to those on combination therapy with rifaximin-\u03b1. The primary outcome was a change in skeletal muscle area (SMA) as measured by computed tomography over two time points. Secondary outcomes included episodes of spontaneous bacterial peritonitis, variceal bleeding, and gastrointestinal Clostridium difficile  infection.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>Of the 142 patients included, 63 were on rifaximin-\u03b1 [35% female, median age 57 (51, 62)], and 79 were on lactulose without rifaximin-\u03b1 [20% female, median age 55 (51, 60)]. Univariate analysis for SMA found that male sex (P  &lt; 0.001), hepatocellular carcinoma presence (P  = 0.024), and greater baseline body mass index (P  = 0.001) were associated with improvement of SMA. Multivariate analysis that adjusted for baseline SMA was performed and found only use of rifaximin-\u03b1 (P  = 0.029) to be associated with improvement of SMA.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>This study demonstrates a significant independent association between rifaximin-\u03b1 therapy and muscle mass in patients with cirrhosis and HE. Prospective studies of rifaximin-\u03b1 therapy examining its impact on sarcopenia are required to assess its potential therapeutic role in this cohort.<\/jats:p>","DOI":"10.4254\/wjh.v17.i4.104056","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T20:19:58Z","timestamp":1745525998000},"source":"Crossref","is-referenced-by-count":3,"title":["Rifaximin-\u03b1 use is associated with improved muscle mass in patients with cirrhosis"],"prefix":"10.4254","volume":"17","author":[{"given":"Thomas","family":"Worland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Hey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Apostolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne Kimberley","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13549"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.07.005"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.006"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000426"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2018.04.007"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-019-0316-6"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30828"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2011.04.014"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5157"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29107"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14516"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000384"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.12.022"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01605-6"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15474"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.007"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2023.0804"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0082"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1317049110"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-010-0679-z"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.004"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.06.007"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S11988"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1091167"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028232"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060042"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.07.002"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03958.x"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14275"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15326"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818800307"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10117-y"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.08.028"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.08.010"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i4\/104056.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i4\/104056.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T20:20:11Z","timestamp":1745526011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i4\/104056.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":34,"journal-issue":{"issue":"4"},"alternative-id":["104056"],"URL":"https:\/\/doi.org\/10.4254\/wjh.v17.i4.104056","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,27]]}}}